Upon completion of this CME session, you should be able to:
1. Identify patients who should undergo drug screening, based on the presentation of clinical effects of performance-enhancing drugs.
2. Select appropriate screening methods for patients suspected of abusing performance-enhancing drugs.
3. Develop management plans directed at the specific drug being abused that take into account the age, sex, ethnicity, cultural background, and readiness to change of the patient.
View technical requirements (opens in a new window).
View CME credit information (opens in a new window).
View disclosures and disclaimers (opens in a new window).
All materials herein are protected by copyright and are for the sole, personal use of the purchaser. No part of the written, oral, and broadcast production may be copied, duplicated, replicated or retransmitted without the prior permission of the applicable copyright owner.
The unauthorized reproduction or distribution of a copyrighted work is illegal. Criminal copyright infringement, including infringement without monetary gain, is investigated by the FBI and is punishable by up to five years in federal prison and a fine of $250,000.
Peter J. Carek, MD, MS, FAAFP, Professor and Chair, Department of Community Health and Family Medicine, University of Florida College of Medicine, Gainesville
- 0.75 AAFP prescribed